1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA BAX CTRPv2 pan-cancer AAC 0.095 0.01
mRNA ATP6V0B CTRPv2 pan-cancer AAC 0.089 0.01
mRNA TTC22 CTRPv2 pan-cancer AAC 0.098 0.01
mRNA DMC1 CTRPv2 pan-cancer AAC -0.096 0.01
mRNA MMP9 CTRPv2 pan-cancer AAC 0.087 0.01
mRNA AL137164.1 CTRPv2 pan-cancer AAC 0.088 0.01
mRNA SLC27A1 CTRPv2 pan-cancer AAC 0.093 0.01
mRNA C5orf38 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA PLRG1 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA CBWD1 CTRPv2 pan-cancer AAC 0.091 0.01
Download CSV